(169 days)
No
The device description and performance studies focus on mechanical and material properties, with no mention of AI/ML algorithms or data processing.
Yes
The device is intended for the "percutaneous removal of retrievable inferior vena cava (IVC) filters," which is a medical procedure to treat a condition within the body.
No
The device is described as a "Snare Retrieval Kit" intended for the "percutaneous removal of retrievable inferior vena cava (IVC) filters." This indicates a therapeutic or interventional function, not a diagnostic one. Its components and testing relate to mechanical performance and biocompatibility for retrieving objects, not for identifying conditions or diseases.
No
The device description explicitly lists multiple physical components such as sheaths, dilators, snares, catheters, and valves, indicating it is a hardware-based medical device kit.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is the "percutaneous removal of retrievable inferior vena cava (IVC) filters". This is a therapeutic procedure performed in vivo (within the body) to remove a medical device.
- Device Description: The components listed (sheaths, dilator, snare, catheter, etc.) are all instruments used for a physical intervention within the body.
- Anatomical Site: The device is used within the "Inferior vena cava (IVC)" and accessed via the "jugular approach", both of which are internal anatomical locations.
- Input Imaging Modality: Fluoroscopic visualization is used to guide the procedure within the body.
- Performance Studies: The performance studies focus on the physical properties and functionality of the device for its intended use in a clinical setting (tensile strength, leakage, corrosion resistance, simulated use, etc.), not on analyzing biological samples.
In Vitro Diagnostics (IVDs) are devices intended for use in the examination of specimens derived from the human body (such as blood, urine, tissue, etc.) to provide information for diagnostic, monitoring, or compatibility purposes. This device does not perform any such analysis of biological samples.
N/A
Intended Use / Indications for Use
Single-Loop Snare Retrieval Kit and Triple-Loop Snare Retrieval Kit are intended for the percutaneous removal of retrievable inferior vena cava (IVC) filters that are no longer medically required, via jugular approach.
Product codes
MMX
Device Description
The Single-Loop Snare Retrieval Kit and Triple-Loop Snare Retrieval Kit consist of a 9F inner sheath, 11F outer sheath, 8F dilator, hemostasis valve with sideport, high pressure stop-cock, 20mm single-loop snare (fully expanded) or 30mm triple-loop snare (fully expanded), 7F snare catheter, Tuohy-Borst Y-port adapter, and torque handle. The snares have radiopaque loops and are preloaded in the snare catheter. The snare catheter, inner sheath, and outer sheath have a radiopaque marker band at the distal tip for enhanced fluoroscopic visualization. This product does not contain natural rubber latex. The maximum recommended infusion rate is 15mL/sec for power injection of contrast.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
inferior vena cava (IVC)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Testing, including:
- Tensile strength
- Liquid leakage
- Air leakage
- Corrosion Resistance
- Snare Assembly Torque Response
- Simulated Use
- Radiopacity
- Luer Testing
- Contrast medium injection
- High Pressure Stopcock Testing
- Flexural modulus and tip flexibility testing
- Design validation testing and summative usability testing
- Radial force testing
Biocompatibility Testing, including:
- Cytotoxicity (ISO 10993-5)
- Sensitization (ISO 10993-10)
- Irritation-Intracutaneous Reactivity (ISO 10993-10)
- Acute Systemic Toxicity (ISO 10993-11)
- Material Mediated Pyrogenicity (ISO 10993-11)
- Hemocompatibility (ISO 10993-4)
- Hemolysis (ISO 10993-4)
- Thromboresistance (ISO 10993-4)
- Complement Activation (ISO 10993-4)
The results of all testing demonstrates that Single-Loop Snare Retrieval Kit and Triple-Loop Snare Retrieval Kit are substantially equivalent to the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5150 Embolectomy catheter.
(a)
Identification. An embolectomy catheter is a balloon-tipped catheter that is used to remove thromboemboli, i.e., blood clots which have migrated in blood vessels from one site in the vascular tree to another.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
December 17, 2019
Argon Medical Devices, Inc. Jo Huang Sr. Regulatory Specialist 1445 Flat Creek Road Athens, Texas 75751
Re: K191758
Trade/Device Name: Single-Loop Snare Retrieval Kit, Triple-Loop Snare Retrieval Kit Regulation Number: 21 CFR 870.5150 Regulation Name: Embolectomy Catheter Regulatory Class: Class II Product Code: MMX Dated: November 15, 2019 Received: November 18, 2019
Dear Jo Huang:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Gregory O'Connell Assistant Director DHT2C: Division of Coronary and Peripheral Intervention Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K191758
Device Name Single-Loop Snare Retrieval Kit Triple-Loop Snare Retrieval Kit
Indications for Use (Describe)
Single-Loop Snare Retrieval Kit and Triple-Loop Snare Retrieval Kit are intended for the percutaneous removal of retrievable inferior vena cava (IVC) filters that are no longer medically required, via jugular approach.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
| Date Prepared: | December 17, 2019 |
|---|---|
| Company: | Argon Medical Devices, Inc. |
| 1445 Flat Creek Road Athens, | |
| Texas 75751 USA | |
| Facility Registration number: 1625425 | |
| Contact: | Jo Huang |
| Senior Regulatory Specialist | |
| Phone: 972-677-9327 | |
| Fax: 903-677-9396 | |
| Email: jo.huang@argonmedical.com | |
| Device trade name: | Single-Loop Snare Retrieval Kit |
| Triple-Loop Snare Retrieval Kit | |
| Device Common | |
| Name: | Device, Percutaneous Retrieval |
| Device classification: | Device, Percutaneous Retrieval |
| Product code, MMX | |
| 21 CFR 870.5150 | |
| Class II | |
| Review Panel: Cardiovascular Devices | |
| Predicate Device(s): | Primary: K152560 Bard Retrieval Kit |
| Reference: K021606 Atrieve Vascular Snare Kit (formerly known as | |
| EnSnare Endo- vascular Snare and Catheter) | |
| K073374 Cook Günther Tulip Vena Cava Filter Retrieval Set | |
| Description of the | |
| device: | The Single-Loop Snare Retrieval Kit and Triple-Loop Snare Retrieval |
| Kit consist of a 9F inner sheath, 11F outer sheath, 8F dilator, hemostasis | |
| valve with sideport, high pressure stop-cock, 20mm single-loop snare | |
| (fully expanded) or 30mm triple-loop snare (fully expanded), 7F snare | |
| catheter, Tuohy-Borst Y-port adapter, and torque handle. The snares | |
| have radiopaque loops and are preloaded in the snare catheter. The snare | |
| catheter, inner sheath, and outer sheath have a radiopaque marker band | |
| at the distal tip for enhanced fluoroscopic visualization. This product | |
| does not contain natural rubber latex. The maximum recommended | |
| infusion rate is 15mL/sec for power injection of contrast. | |
| Indications for Use: | Single-Loop Snare Retrieval Kit and Triple-Loop Snare |
| Retrieval Kit are intended for the percutaneous removal of retrievable | |
| inferior vena cava (IVC) filters that are no longer medically required, | |
| via jugular approach. |
4
Technological Characteristics:
Comparisons of Single-Loop Snare Retrieval Kit and Triple-Loop Snare Retrieval Kit and predicate devices show that the technological characteristics such as product performance, design and intended use are substantially equivalent to the current marketed predicate devices.
The Single-Loop Snare Retrieval Kit and Triple-Loop Snare Retrieval Kit are similar in design – device dimensional specifications, intended use, shelf life, materials and sterilization process of that of the predicate devices.
Performance tests (Non-Clinical):
No performance standards have been established under section 514, performance standards, of the Food, Drug and Cosmetic Act for these devices. A series of testing was conducted in accordance with protocols based on requirements outlined in guidance's and industry standards and the below were shown to meet the acceptance criteria that were determined to demonstrate substantial equivalence.
The Single-Loop Snare Retrieval Kit and Triple-Loop Snare Retrieval Kit are substantially equivalent to the specified predicate devices based on comparisons of the device functionality, technological characteristics, and Indications for Use.
The device design has been subjected to and have passed the following tests to ensure reliable design and performance under the specified testing parameters:
Performance Testing, including:
- Tensile strength
- Liquid leakage
- Air leakage
- Corrosion Resistance
- Snare Assembly Torque Response
- Simulated Use
- Radiopacity
- Luer Testing
- Contrast medium injection
- High Pressure Stopcock Testing
- Flexural modulus and tip flexibility testing
- Design validation testing and summative usability testing
- Radial force testing
Biocompatibility Testing, including:
- Cytotoxicity (ISO 10993-5)
5
| • Sensitization (ISO 10993-10) | |
|---|---|
| • Irritation-Intracutaneous Reactivity (ISO 10993-10) | |
| • Acute Systemic Toxicity (ISO 10993-11) | |
| • Material Mediated Pyrogenicity (ISO 10993-11) | |
| • Hemocompatibility (ISO 10993-4) | |
| • Hemolysis (ISO 10993-4) | |
| • Thromboresistance (ISO 10993-4) | |
| • Complement Activation (ISO 10993-4) | |
| Substantial | |
| Equivalence: | Based on the Indication for Use, design, safety and performance testing, |
| the Single Loop Snare Retrieval Kit and Triple Loop Snare Retrieval Kit | |
| meet the requirements for its intended use and are substantially equivalent | |
| to the predicate devices. | |
| Conclusion: | The results of all testing demonstrates that Single-Loop Snare |
| Retrieval Kit and Triple-Loop Snare Retrieval Kit are substantially | |
| equivalent to the predicate devices |